Skip to main content
Top
Published in: Neurological Sciences 1/2014

01-05-2014 | FICEF SYMPOSIUM - Headache in the front line: from pharmacist to general practitioner

Symptomatic treatment of migraine: from scientific evidence to patient management

Authors: Gian Camillo Manzoni, P. Torelli

Published in: Neurological Sciences | Special Issue 1/2014

Login to get access

Abstract

All migraine patients need symptomatic treatment to stop individual attacks or, at least, significantly relieve pain. When attacks are very frequent (more than 3 days of headache per month on average), they will also need preventive treatment. The first physician the patient must address to for preventive treatment is the general practitioner (GP). If the medication prescribed by the GP is not effective or there is overuse of symptomatic drugs, the patient will have to be referred to a neurologist or a headache clinic. The drugs to be used as symptomatic treatment are triptans and non-steroidal anti-inflammatory drugs. Combination therapy with antiemetics is also important. While specialists will base their therapeutic decisions on guidelines in the literature and on their personal experience, GPs do not yet have any easy-to-use tools to support them. To fill this gap, an algorithm is proposed here that can be easily used by GPs to make decisions during their patients’ migraine attacks.
Literature
1.
go back to reference Lipton RB, Stewart WF, Simon D (1998) Medical consultation for migraine: results from the American Migraine Study. Headache 38:87–96PubMedCrossRef Lipton RB, Stewart WF, Simon D (1998) Medical consultation for migraine: results from the American Migraine Study. Headache 38:87–96PubMedCrossRef
2.
go back to reference Seng EK, Holroyd KA (2013) Optimal use of acute headache medication: a qualitative examination of behaviors and barriers to their performance. Headache 53:1438–1450PubMed Seng EK, Holroyd KA (2013) Optimal use of acute headache medication: a qualitative examination of behaviors and barriers to their performance. Headache 53:1438–1450PubMed
3.
go back to reference Torelli P, Manzoni GC (2012) A redefinition of primary headache: chronic migraine. Neurol Sci 33:S17–S20PubMedCrossRef Torelli P, Manzoni GC (2012) A redefinition of primary headache: chronic migraine. Neurol Sci 33:S17–S20PubMedCrossRef
4.
go back to reference Manzoni GC, Grisendi I, Torelli P (2011) ICHD-3: what changes do we need regarding migraine? Curr Pain Headache Rep 15:170–176PubMedCrossRef Manzoni GC, Grisendi I, Torelli P (2011) ICHD-3: what changes do we need regarding migraine? Curr Pain Headache Rep 15:170–176PubMedCrossRef
5.
go back to reference Antonaci F, Valade D, Lanteri-Minet M, Láinez JM, Jensen R, Steiner TJ (2008) European Headache Federation and Lifting The Burden: the global campaign to reduce the burden of headache worldwide. Proposals for the organisation of headache services in Europe. Intern Emerg Med 3:S25–S28PubMedCrossRef Antonaci F, Valade D, Lanteri-Minet M, Láinez JM, Jensen R, Steiner TJ (2008) European Headache Federation and Lifting The Burden: the global campaign to reduce the burden of headache worldwide. Proposals for the organisation of headache services in Europe. Intern Emerg Med 3:S25–S28PubMedCrossRef
6.
go back to reference Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS (2009) EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol 16:968–981PubMedCrossRef Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS (2009) EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol 16:968–981PubMedCrossRef
7.
go back to reference Agenzia Nazionale per i Servizi Sanitari Regionali (Age.na.s) (2011) Cefalea nell’adulto: Linee guida nazionali di riferimento per la prevenzione e la terapia Agenzia Nazionale per i Servizi Sanitari Regionali (Age.na.s) (2011) Cefalea nell’adulto: Linee guida nazionali di riferimento per la prevenzione e la terapia
8.
go back to reference Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E (2012) Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78:1337–1345PubMedCentralPubMedCrossRef Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E (2012) Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78:1337–1345PubMedCentralPubMedCrossRef
9.
go back to reference Abrignani G, Ferrante T, Castellini P, Lambru G, Beghi E, Manzoni GC, Torelli P (2012) Description and validation of an Italian ICHD-II based questionnaire for use in epidemiological research. Headache 52:1262–1282PubMedCrossRef Abrignani G, Ferrante T, Castellini P, Lambru G, Beghi E, Manzoni GC, Torelli P (2012) Description and validation of an Italian ICHD-II based questionnaire for use in epidemiological research. Headache 52:1262–1282PubMedCrossRef
10.
go back to reference Greppi E, Sicuteri F (1964) L’emicrania. Motivi di fisiopatogenesi e di terapia. Relazione al 65°Congresso della Società Italiana di Medicina Interna Greppi E, Sicuteri F (1964) L’emicrania. Motivi di fisiopatogenesi e di terapia. Relazione al 65°Congresso della Società Italiana di Medicina Interna
11.
go back to reference Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT (2010) A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med 56:1–6PubMedCrossRef Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT (2010) A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med 56:1–6PubMedCrossRef
Metadata
Title
Symptomatic treatment of migraine: from scientific evidence to patient management
Authors
Gian Camillo Manzoni
P. Torelli
Publication date
01-05-2014
Publisher
Springer Milan
Published in
Neurological Sciences / Issue Special Issue 1/2014
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-014-1734-4

Other articles of this Special Issue 1/2014

Neurological Sciences 1/2014 Go to the issue

FICEF SYMPOSIUM - Headache in the front line: from pharmacist to general practitioner

Prevention, education and information: the role of the community pharmacist in the management of headaches